Finnadvance is bridging the gap between in-vitro and in-vivo research with its microfluidic organ-on-chips for pharmaceutical drug research and development. With industry leading high throughput microphysiological culture platforms, complex in vivo biomechanical cues are mimicked on the in vitro cultures.
-
- Founding year:
2019
-
- Development phase:
Market-ready
-
- Funding stage:
A round
-
- Website:
-
- Contact person info:
science(at)finnadvance.com
-
- Team members:
18
-
- Article:
Read an article about Finnadvance.
Recent Comments